Investors.abbvie.com

Investor Overview AbbVie

AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world's greatest health challenges. AbbVie discovers, develops, and commercializes advanced therapies that have an impact on people's lives. Today, our passionate AbbVie team has approximately ~50,000 employees working together to help patients

Actived: 9 days ago

URL: https://investors.abbvie.com/

41st Annual J.P. Morgan Healthcare Conference AbbVie

WebThe Investor Relations website contains information about AbbVie's business for stockholders, potential investors, and financial analysts.

Category:  Health Go Health

AbbVie Reports Full-Year and Fourth-Quarter 2023 …

WebReports Full-Year Diluted EPS of $2.72 on a GAAP Basis, a Decrease of 59.0 Percent; Adjusted Diluted EPS of $11.11, a Decrease of 19.3 Percent; These Results …

Category:  Health Go Health

AbbVie Reports Full-Year and Fourth-Quarter 2020 …

WebNORTH CHICAGO, Ill., Feb. 3, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced financial results for the fourth quarter and full year ended December 31, 2020. "We …

Category:  Health Go Health

AbbVie to Host Third-Quarter 2023 Earnings Conference …

WebAbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. …

Category:  Medical,  Medicine Go Health

J.P. Morgan Healthcare Conference

WebVersatile atypical antipsychotic that provides strong efficacy across multiple symptoms, with minimal impact on weight, lipids and fasting blood glucose. Recently …

Category:  Health Go Health

AbbVie Reports Full-Year and Fourth-Quarter 2022 …

WebReports Full-Year Diluted EPS of $6.63 on a GAAP Basis, an Increase of 2.8 Percent; Adjusted Diluted EPS of $13.77, an Increase of 16.4 Percent; These Results …

Category:  Health Go Health

AbbVie to Present at the Goldman Sachs 44th Annual …

WebNORTH CHICAGO, Ill., June 6, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Wednesday, June …

Category:  Health Go Health

AbbVie to Present at the 41st Annual J.P. Morgan …

WebNORTH CHICAGO, Ill., Jan. 3, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023. …

Category:  Health Go Health

AbbVie to Present at the 40th Annual J.P. Morgan …

WebNORTH CHICAGO, Ill., Jan. 4, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 40 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, …

Category:  Health Go Health

AbbVie Reports First-Quarter 2024 Financial Results AbbVie

WebReports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results …

Category:  Health Go Health

J.P. Morgan Healthcare Conference AbbVie

WebThe Investor Relations website contains information about AbbVie's business for stockholders, potential investors, and financial analysts.

Category:  Health Go Health

A decade Endless of impact possibilities

Webserious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key …

Category:  Medical Go Health

Financial Reports AbbVie

WebThe Investor Relations website contains information about AbbVie's business for stockholders, potential investors, and financial analysts.

Category:  Health Go Health

AbbVie Reports Third-Quarter 2023 Financial Results AbbVie

WebReports Third-Quarter Diluted EPS of $1.00 on a GAAP Basis, a Decrease of 54.8 Percent; Adjusted Diluted EPS of $2.95, a Decrease of 19.4 Percent; These Results …

Category:  Health Go Health

AbbVie to Present at the 40th Annual J.P. Morgan Healthcare …

WebEvent Details. Title. AbbVie to Present at the 40th Annual J.P. Morgan Healthcare Conference. Date and Time. 01/11/22 2:45 pm CST. Supporting Materials. …

Category:  Health Go Health

AbbVie to Host Fourth-Quarter 2022 Earnings Conference Call

WebNORTH CHICAGO, Ill., Jan. 5, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its fourth-quarter 2022 financial results on Thursday, February 9, 2023, before the market …

Category:  Health Go Health

AbbVie to Present at the Cowen 40th Annual Health Care …

WebNORTH CHICAGO, Ill., Feb. 19, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Cowen 40 th Annual …

Category:  Health Go Health

AbbVie Immunology Strategy and Long-Term Outlook

WebSkyrizi and Rinvoq are highly differentiated assets and represent tremendous long-term value, with risk-adjusted sales in 2025 expected to exceed $15 billion. …

Category:  Health Go Health

AbbVie to Present at the Cowen 42nd Annual Health Care …

WebAbbVie to Present at the Cowen 42nd Annual Health Care Conference 03/08/22 11:50 am CST Webcast Presentation. Click here for webcast. Event Details: …

Category:  Health Go Health

J.P. Morgan Healthcare Conference

WebRisankizumab demonstrating a very high level of efficacy, durable effect and safety across a broad set of indications, with convenience of quarterly dosing; expected to launch in 5+ …

Category:  Health Go Health